Based on the link between obesity and AEH/EC, we hypothesized that the combination of a GLP-1R agonist and levonorgestrel would be useful as a novel treatment or prevention regimen and tested this hypothesis in preclinical models using EC cell lines and patient-derived organoids. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.